PDE / ADE · OEL / OEB

Home→PDE/ADE · OEL/OEB Profiles → Calcium Carbonate→

Calcium Carbonate PDE report and OEL report profile

Project-specific health-based exposure limit and occupational toxicology assessment support. The agreed scope may include PDE/ADE derivation, OEL derivation and OEB/OHC banding, based on the exact substance form, available evidence and intended product or workplace context.

CAS Registry Number
471-34-1
Molecular formula
CCaO3
Molecular weight
100.09 g/mol
Drug class
Inorganic calcium saltcalcium supplement, antacid and phosphate-binding agent
Mechanism of action
Dissociates in the gastrointestinal tract to provide calcium ions. Calcium carbonate neutralises gastric hydrochloric acid and, in the intestine, binds phosphate to form poorly absorbed calcium-phosphate complexes; the product formulation and administration with food determine its use.
Indications / reported uses
  • Calcium supplementation and prevention or treatment of inadequate calcium intake
  • Symptomatic relief of acid-related dyspepsia and heartburn in authorised antacid formulations
  • Phosphate binding in selected patients with chronic kidney disease where specifically authorised; monitor calcium and phosphate balance

Sources: US DailyMed — Calcium carbonate products · NIH Office of Dietary Supplements — Calcium fact sheet · FDA product information

View request basketPrefer email? info@toxwriter.com
PDE / ADE derivationOEL derivationOEB / OHC banding
Assessment scope

PDE/ADE and OEL/OEB assessment

ToxWriter provides project-specific support for Calcium Carbonate PDE/ADE, OEL and OEB/OHC assessments. This combined profile covers the Calcium Carbonate Permitted Daily Exposure (PDE) report (the Calcium Carbonate PDE report); Acceptable Daily Exposure (ADE) is the corresponding health-based daily exposure terminology. It also covers the Calcium Carbonate Occupational Exposure Limit (OEL) report (the Calcium Carbonate OEL report). PDE/ADE derivation and workplace exposure assessment are distinct scientific outputs; a band is not a numerical OEL.

Assessment may cover

  • PDE/ADE derivation using relevant toxicological evidence, critical effects, a justified point of departure and adjustment factors.
  • OEL derivation considering relevant hazards, exposure route, duration and workplace conditions.
  • OEB/OHC banding where requested and supported by the evidence; an exposure band is not a numerical OEL.
  • Review of substance identity, evidence quality, uncertainty and data gaps.
PDE/ADE, OEL & OEB/OHC regulatory framework

The EMA HBEL guideline informs PDE/ADE assessments in relevant shared-facility contexts. ECHA and HSE sources address workplace exposure limits; NIOSH provides occupational exposure-banding guidance. The applicable framework depends on the assessment question and jurisdiction.